Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...

NanoCas, an ultracompact nuclease, enables efficient muscle editing in NHPs using a single AAV - advancing gene editing for hard-to-target tissues.

The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

Panning for CTAP. By sifting through the genome of K562 myeloid progenitor cancer cells, Muhar and colleagues identified genes that mediate the breakdown of proteins (green) carrying C-terminal amides ...

Northwestern Medicine scientists have uncovered new details explaining how poxviruses manipulate host cells to enhance their ...

A research group at Umeå University has developed new advanced light-controlled tools that enable precise control of proteins in real time in living cells.

Learn more about whether Catalyst Pharmaceuticals, Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

CRISPR-Cas9 genome editing exploits the CRISPR ... this issue by adding polyaspartate tags to the termini of the Cas protein, enabling effective genome manipulation in Streptomyces.

Using fermentation, University of Alberta researchers have come up with a way to produce higher amounts of a healthy fatty ...

New study reveals that TLE6 protein deficiency causes male infertility in mice. These findings suggest potential genetic ...